ArticleBMC cancer2025
Ultrasound feature-based nomogram model for predicting extrathyroidal extension in papillary thyroid carcinoma.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Diagnostic performance and generalizability of a clinical-ultrasound radiomics model for predicting extrathyroidal extension in thyroid carcinoma: a retrospective study.Annals of medicine · 2026Article
- Preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma: a nomogram integrating dual-plane ultrasound-based radiomics and clinical features.Gland surgery · 2026Article
- Article
- Clinicopathological Significance of Ultrasound Risk Features and the Taller-Than-Wide Sign for Tumor Advancement in Differentiated Thyroid Cancer: A Single-Center Analysis.Cancer management and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe ultrasound diagnostic system for extrathyroidal extension (ETE) of papillary thyroid carcinoma (PTC) has not been thoroughly explored. To develop and validate a nomogram model based on ultrasound features to predict ETE of papillary thyroid carcinoma for preoperative assessment.
methodsThe training set retrospectively included 560 patients from two hospitals with preoperative ultrasound images showing capsule contact and confirmed as unifocal PTC by surgical pathology. The external validation set prospectively included 150 PTC patients with similar features and dynamic ultrasound videos. Univariate and multivariate logistic regression analyses were used to identify independent predictors of ETE in PTC, and an ETE nomogram prediction model was constructed to predict the risk of ETE in capsule-contacting PTC. The predictive efficiency of the model was evaluated using receiver operating characteristic (ROC) curve and calibration curves, and the clinical value of the model was determined through decision curve analysis (DCA).
resultsAmong 710 capsule-contacting unifocal PTC patients, the incidence of ETE was 66.62% (473/710). Independent predictors of ETE were: Capsule bulging (OR = 8.951, 95%CI: 5.192–15.134), capsule contact angle ≥ 90° (OR = 2.331, 95%CI: 1.405–3.868), capsule contact extent ≥ 25% (OR = 5.708, 95%CI: 3.429–9.503), irregular morphology (OR = 1.856, 95%CI: 1.114–3.094), and coarse margins (OR = 4.198, 95%CI: 2.396–7.352). Based on these factors, an ETE nomogram diagnostic prediction model for PTC was established. The model’s ROC curve demonstrated an area under the curve (AUC) of 0.887 (95% CI: 0.857–0.917), with diagnostic sensitivity, specificity, and accuracy of 0.811, 0.799 and 0.807, respectively. The AUC of the external validation set was 0.896 (95% CI: 0.847–0.945), with diagnostic sensitivity, specificity, and accuracy of 0.862, 0.762, and 0.820, respectively. The calibration curve showed good consistency between the predicted and actual probabilities of ETE. DCA showed that the model had good clinical application value.
conclusionThe ETE nomogram scoring prediction model based on conventional ultrasound features can provide a relatively convenient and intuitive preoperative quantitative assessment of ETE in PTC, serving as a reference for clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.